Radiopharm Theranostics Limited (RADX) Revenue History
Annual and quarterly revenue from 2021 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RADX Revenue Growth
Revenue Breakdown
RADX's revenue distribution by segment and geography
By Geography
RADX Revenue Analysis (2021–2024)
As of May 8, 2026, Radiopharm Theranostics Limited (RADX) generated trailing twelve-month (TTM) revenue of $0.
Looking at the longer-term picture, RADX's historical revenue data shows a 3-year CAGR of +643.8%. The company achieved its highest annual revenue of $3.6 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including RNW (+50.5% YoY), LNTH (+0.6% YoY), and AGEN (+10.4% YoY). Compare RADX vs RNW →
RADX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RADXCurrent | $0 | - | - | -1050.6% | |
 RNW | $97.1B | +50.5% | +14.9% | 53.5% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 PRTC | $5M | -53.7% | -11.0% | -2114.7% |
RADX Historical Revenue Data (2021–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $3.6M | +1114.3% | $39K | 1.1% | $-38,173,865 | -1050.6% |
| 2023 | $299K | +2.3% | $299K | 100.0% | $-36,620,852 | -12238.4% |
| 2022 | $292K | +3210.6% | $292K | 100.0% | $-34,508,085 | -11803.3% |
| 2021 | $9K | - | $9K | 100.0% | $-19,916,352 | -225527.7% |
See RADX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RADX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RADX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRADX — Frequently Asked Questions
Quick answers to the most common questions about buying RADX stock.
Is RADX's revenue growth accelerating or slowing?
RADX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RADX's long-term revenue growth rate?
Radiopharm Theranostics Limited's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RADX's revenue distributed by segment?
RADX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2024 are available for download. Segment mix reveals concentration and diversification trends.